MUTAGEN TREATMENT AS A MEANS FOR SELECTING IMMUNOGENIC VARIANTS FROM OTHERWISE POORLY IMMUNOGENIC MALIGNANT MURINE TUMORS
- 1 January 1983
- journal article
- research article
- Vol. 43 (1) , 125-132
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.The Journal of Experimental Medicine, 1980
- Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low‐metastatic H‐2 heterozygous tumor cell line into an H‐2 incompatible parental strainInternational Journal of Cancer, 1978
- Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.Proceedings of the National Academy of Sciences, 1978
- Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.Proceedings of the National Academy of Sciences, 1977